We are live on
!
Find out more
RCM
Raleigh Capital Management Portfolio holdings
AUM
$313M
1-Year Est. Return
23.55%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+23.55%
3 Year Est. Return
+71.82%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$235M
AUM Growth
+$3.12M
(+1.3%)
Cap. Flow
+$471K
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
22.94%
Holding
1,032
New
71
Increased
437
Reduced
244
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$2.91M |
| 2 |
iShares US Pharmaceuticals ETF
IHE
|
+$1.69M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.2M |
| 4 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$1.15M |
| 5 |
State Street SPDR Portfolio Emerging Markets ETF
SPEM
|
+$729K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.93M |
| 2 |
iShares US Aerospace & Defense ETF
ITA
|
+$1.88M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$1.35M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.06M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$833K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Financials | 8.89% |
| 3 | Healthcare | 7.84% |
| 4 | Consumer Staples | 5.97% |
| 5 | Utilities | 5.92% |
Similar funds
WMIG
JIC
FA
MIM
PAM
KA
SL
TF
Raleigh Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Raleigh Capital Management held 1,032 positions worth $235M, up 1.3% from $232M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Raleigh Capital Management's Q2 2024 filing shows 71 new, 437 increased, 244 reduced and 48 closed positions. Its largest new stake was iShares US Pharmaceuticals ETF: 25,820 shares worth $1.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.93M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.
- Raleigh Capital Management's largest Q2 2024 buy was iShares US Pharmaceuticals ETF: 25,820 shares worth $1.71M.
- Raleigh Capital Management added most to State Street SPDR Portfolio Developed World ex-US ETF in Q2 2024, an estimated $2.91M increase.
- Raleigh Capital Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.93M.
- Raleigh Capital Management fully exited FT Vest US Equity Buffer ETF July in Q2 2024, selling an estimated $393K.
- Raleigh Capital Management's ten largest holdings make up 23% of its $235M portfolio in Q2 2024.
- Raleigh Capital Management opened 71 new positions and closed 48 in Q2 2024.
- Raleigh Capital Management's portfolio value rose 1.3% quarter-over-quarter to $235M.
Based on Raleigh Capital Management's 13F filing for Q2 2024, filed 31 Jul 2024.